Top Menu

Selling Sex in DTC

I must start off by saying that I qualify for free Viagra, still being on the retiree Pfizer medical plan. Actually I am a “firee” not a retiree, but I qualify anyway for continued coverage, having worked enough years at Warner-Lambert to continue on the Pfizer plan after they took us over. That bias towards […]

Continue Reading

The End of a Great Publication

Most of you know that Med Ad News has ceased publication, along with web properties PharmaLive and Pharmalot. Med Ad News had become thinner and thinner lately indicating slim ad sales. There is no doubt that printed magazines are hurting in general. The decision to end PharmaLive and Pharmalot also indicate it is hard to make money on content […]

Continue Reading

Obamacare's Unintented Consquence: The Rise of Consumer Information

Despite the flattening of DTC spending in the past few years, there is a tidal wave of DTC opportunities coming for health marketers. I will broaden the definition of DTC to beyond drugs and devices and include health services which include health providers, clinics, and diagnostics. What people are realizing about Obamacare is that cost […]

Continue Reading

What Obamacare Means for Big Pharma

Big Pharma agreed to support Obamacare with significant price subsidies for consumers. They assumed that giving this support would be offset by new customers through expanded access to coverage. They also got assurances that Medicare would not negotiate drug prices directly. The mess that is Obamacare may not work out the way the drug makers […]

Continue Reading